HIV: You have options

I am thinking about starting HIV therapy.

I am on my first HIV regimen.

I have been on HIV therapy for a long time.

Click here for News about ISENTRESS

As seen in clinical studies lasting 96 weeks, patients being treated with HIV medication
for the first time who took ISENTRESS plus Truvada:

May reach a reduced viral load to undetectable (less than 400 copies/mL or less than
50 copies/mL) and an increase in CD4 (T) cell counts (depending on the test used). ISENTRESS may not have these effects in all patients
Had a low rate of side effects
- The most common side effect of moderate to severe intensity (that interfered
  with or kept patients from performing daily activities) was trouble sleeping
- This side effect occurred more often in patients taking ISENTRESS plus
  Truvada (4%) versus Sustiva plus Truvada (3%)
Experienced less effect on LDL cholesterol ("bad" cholesterol)
- Cholesterol increased an average of 7 mg/dL with ISENTRESS plus Truvada
  versus 21 mg/dL with Sustiva plus Truvada
  - When they began the study, the average LDL cholesterol of patients on ISENTRESS plus Truvada was 96 mg/dL versus 93 mg/dL for those on Sustiva plus Truvada

ISENTRESS is an anti-HIV medicine used for the treatment of HIV. ISENTRESS must be used with other anti-HIV medicines, which may increase the likelihood of response to treatment. It is important that you remain under your doctor’s care. ISENTRESS will NOT cure HIV infection or reduce your chances of passing HIV to others through sexual contact, sharing needles, or being exposed to your blood.

The safety and effectiveness of ISENTRESS in children has not been studied.

A condition called Immune Reconstitution Syndrome can happen in some patients with advanced HIV infection (AIDS) when anti-HIV treatment is started. Signs and symptoms of inflammation from opportunistic infections may occur as the medicines work to treat the HIV infection and strengthen the immune system. Call your doctor right away if you notice any signs or symptoms of an infection after starting ISENTRESS.

Contact your doctor immediately if you experience unexplained muscle pain, tenderness, or weakness while taking ISENTRESS. This is because on rare occasions muscle problems can be serious and can lead to kidney damage.

When ISENTRESS has been given with other anti-HIV drugs, side effects included nausea, headache, tiredness, weakness, trouble sleeping, stomach pain, dizziness, depression, and suicidal thoughts and actions. Other side effects include: rash, severe skin reactions, feeling anxious, paranoia, low blood platelet count, diarrhea, liver failure.

Mild rash occurred more often in patients taking ISENTRESS plus Prezista than with either drug alone.

People taking ISENTRESS may still develop infections, including opportunistic infections or other conditions that occur with HIV infection.

Tell your doctor about all of your medical conditions, including if you have any allergies, are pregnant or plan to become pregnant, or are breast-feeding or plan to breast-feed. ISENTRESS is not recommended for use during pregnancy. Women with HIV should not breast-feed because their babies could be infected with HIV through their breast milk.

Tell your doctor about all the medicines you take, including prescription medicines like rifampin (a medicine used to treat infections such as tuberculosis), non-prescription medicines, vitamins, and herbal supplements.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please read the Prescribing Information and Patient Product Information.

IMMU-1004374-0001-05/11

Sustiva is a registered trademark of Bristol-Myers Squibb
Truvada is a registered trademark of Gilead Sciences, Inc.
Prezista is a registered trademark of Tibotec, Inc.